
Sign up to save your podcasts
Or


Dr. Martin Hirst is Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre, Director of the Michael Smith Laboratory and Professor at the University of British Columbia.
This interview, co-hosted by Alvin Qiu and Benjamin Lebeau, focuses on Dr. Hirst’s career and future perspectives on epigenetic approaches for cancer therapy.
By The CEEHRC NetworkDr. Martin Hirst is Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre, Director of the Michael Smith Laboratory and Professor at the University of British Columbia.
This interview, co-hosted by Alvin Qiu and Benjamin Lebeau, focuses on Dr. Hirst’s career and future perspectives on epigenetic approaches for cancer therapy.